Saito Biotech: Guojin Securities 2024 Semi-Annual Follow-up Report 2024 Semi-Annual Continuous Supervision and Follow-up Report
Saito Biotech: Announcement on preparing for asset impairment
Saito Biotech: Special Report on the Storage and Use of Funds Raised for the Semi-Annual Year 2024
Saito Biotech: 2024 Semi-Annual Report
Saito Biotech: Announcement of Board Resolutions
Saito Biotech: Announcement on terminating the acquisition of 60% of the shares of Silver Valley Pharmaceutical Co., Ltd.
Saito Biotech: Special Report on Non-operating Capital Occupation and Other Related Capital Transactions for the Semi-Annual Year 2024
Saito Biotech: Progress announcement on providing guarantees for wholly-owned subsidiaries
Saito Biotech: 2024 Semi-Annual Report Summary
Saito Biotech: Public Opinion Management System (August 2024)
Saito Biotech: Announcement of Supervisory Board Resolutions
Shandong Sito Bio-technology: Announcement regarding subsidiary's compliance check for pharmaceutical Good Manufacturing Practice (GMP).
Shandong Sito Bio-technology: Announcement regarding the subsidiary receiving notification of approval for the listing application of chemical raw materials.
Shandong Sito Bio-technology: Announcement on the Release of Pledged Shares by Controlling Shareholders of the Company
Shandong Sito Bio-technology: Announcement Regarding Abnormal Fluctuations in Stock Trading
Shandong Sito Bio-technology: Announcement of Annual Equity Distribution Implementation in 2023
Shandong Sito Bio-technology: Announcement of Resolutions of the Shareholders' Meeting for the Fiscal Year 2023
Shandong Sito Bio-technology: Legal opinion on the 2023 Annual Shareholders' Meeting of Shandong Sito Bio-Technology Co., Ltd. by Guohao Law Firm (Hangzhou).
Shandong Sito Bio-technology: Announcement on the Notice of the 2023 Annual Shareholders' Meeting (with additional provisional proposals)
Shandong Sito Bio-technology: Announcement of the resolution of the fourth meeting of the fourth board of directors.
No Data
No Data